BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 32498686)

  • 1. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
    J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COVID-19 pandemic.
    Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC; Silverman RH
    Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
    [No Abstract]   [Full Text] [Related]  

  • 4. Respiratory Virus Infections: Understanding COVID-19.
    Subbarao K; Mahanty S
    Immunity; 2020 Jun; 52(6):905-909. PubMed ID: 32497522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    Nowill AE; de Campos-Lima PO
    J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COVID-19- what have we learned and where are we heading?].
    Gudnason T
    Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology of COVID-19: Current State of the Science.
    Vabret N; Britton GJ; Gruber C; Hegde S; Kim J; Kuksin M; Levantovsky R; Malle L; Moreira A; Park MD; Pia L; Risson E; Saffern M; Salomé B; Esai Selvan M; Spindler MP; Tan J; van der Heide V; Gregory JK; Alexandropoulos K; Bhardwaj N; Brown BD; Greenbaum B; Gümüş ZH; Homann D; Horowitz A; Kamphorst AO; Curotto de Lafaille MA; Mehandru S; Merad M; Samstein RM;
    Immunity; 2020 Jun; 52(6):910-941. PubMed ID: 32505227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Insights into Immune Responses during COVID-19.
    St John AL; Rathore APS
    J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-A Tough Opponent for the Immune System.
    Nasab MG; Saghazadeh A; Rezaei N
    Arch Med Res; 2020 Aug; 51(6):589-592. PubMed ID: 32532524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
    Papachristodoulou E; Kakoullis L; Parperis K; Panos G
    Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine storm and the prospects for immunotherapy with COVID-19.
    Calabrese LH
    Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten things we learned about COVID-19.
    Cecconi M; Forni G; Mantovani A
    Intensive Care Med; 2020 Aug; 46(8):1590-1593. PubMed ID: 32504103
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2: the emergence of a viral pathogen causing havoc on human existence.
    Prasad A; Prasad M
    J Genet; 2020; 99(1):. PubMed ID: 32482926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status could determine efficacy of COVID-19 therapies.
    Cully M
    Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.